Literature DB >> 8226139

Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia.

F Cucca1, F Muntoni, R Lampis, F Frau, L Argiolas, M Silvetti, E Angius, A Cao, S De Virgiliis, M Congia.   

Abstract

The Sardinian population has an extremely high incidence of IDDM (30.2 of 100.000 in the age group of 0-14 years). This study reports the molecular characterization of HLA class II genes in 120 IDDM sporadic patients and 89 healthy subjects of Sardinian origin. Compared with other Caucasians, both Sardinian patients and controls had an unusual distribution of haplotypes and genotypes. In particular, there was a high gene frequency of the DRB1*0301, DQA1*0501, DQB1*0201 susceptibility haplotype both in patients (0.58) and controls (0.23) while a reduction of the DRB1*1501, DQA1*0102, DQB1*0602 protective haplotype (0.03) was observed in the healthy population. This distribution may partially explain the high incidence of IDDM reported in Sardinia. The analysis of the DQ beta 57 and DQ alpha 52 residues showed that the absence of Asp 57 and the presence of Arg 52 were associated with IDDM in a dose-response manner. On the other hand, we found that (a) a very similar distribution of these residues was found when comparing Sardinians with another healthy Caucasian population from the same latitude but with a lower rate of IDDM incidence; (b) several genotypes encoding the identical DQ alpha 52/DQ beta 57 phenotype carried very different relative risks; and (c) the DRB1*0403, DQA1*0301, DQB1*0304 haplotype (DQ beta 57 Asp-neg and DQ alpha 52 Arg-pos) was found in 40% of the DR4-positive controls but not in patients (p = 0.00034), while the DRB1*0405, DQA1*0301, and DQB1*0302 haplotype carrying the same residues at the same positions was found in 70% of the DR4-positive patients and in only one control (p = 0.00003). These findings suggest that IDDM susceptibility cannot be completely explained by the model in which only DQ alpha 52 and DQ beta 57 residues are taken into account.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226139     DOI: 10.1016/0198-8859(93)90146-r

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  25 in total

1.  Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population.

Authors:  Rachida Raache; Khadidja Belanteur; Habiba Amroun; Amel Benyahia; Amel Heniche; Malha Azzouz; Safia Mimouni; Thibaud Gervais; Dominique Latinne; Aissa Boudiba; Nabila Attal; Mohamed Cherif Abbadi
Journal:  Clin Vaccine Immunol       Date:  2012-02-08

2.  HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method.

Authors:  A M Valdes; S McWeeney; G Thomson
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  Detecting disease-predisposing variants: the haplotype method.

Authors:  A M Valdes; G Thomson
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

4.  The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families.

Authors:  J A Noble; A M Valdes; M Cook; W Klitz; G Thomson; H A Erlich
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

5.  Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family.

Authors:  C F Verge; P Vardi; S Babu; F Bao; H A Erlich; T Bugawan; D Tiosano; L Yu; G S Eisenbarth; P R Fain
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

6.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

7.  The HLA class I A locus affects susceptibility to type 1 diabetes.

Authors:  Janelle A Noble; Ana M Valdes; Teodorica L Bugawan; Raymond J Apple; Glenys Thomson; Henry A Erlich
Journal:  Hum Immunol       Date:  2002-08       Impact factor: 2.850

8.  Association of MHC SNP genotype with susceptibility to type 1 diabetes: a modified survival approach.

Authors:  E McKinnon; G Morahan; D Nolan; I James
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

9.  HLA genotyping in the international Type 1 Diabetes Genetics Consortium.

Authors:  Josyf C Mychaleckyj; Janelle A Noble; Priscilla V Moonsamy; Joyce A Carlson; Michael D Varney; Jeff Post; Wolfgang Helmberg; June J Pierce; Persia Bonella; Anna Lisa Fear; Eva Lavant; Anthony Louey; Sean Boyle; Julie A Lane; Paul Sali; Samuel Kim; Rebecca Rappner; Dustin T Williams; Letitia H Perdue; David M Reboussin; Brian D Tait; Beena Akolkar; Joan E Hilner; Michael W Steffes; Henry A Erlich
Journal:  Clin Trials       Date:  2010-07-01       Impact factor: 2.486

10.  HLA-DQB1* alleles and genetic susceptibility to type 1 diabetes mellitus.

Authors:  Youssef M Mosaad; Fatma A Auf; Shereen S Metwally; Ashraf A Elsharkawy; Amany K El-Hawary; Rasha H Hassan; Ziyad E Tawhid; Farha A El-Chennawi
Journal:  World J Diabetes       Date:  2012-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.